Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 7:30 am ET. A link to the live and archived webcast may be accessed on the Sotera Health website under the Inve
CLEVELAND, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Sotera Health LLC (Formerly Known As Sterigenics International, Inc.) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 7:30 am ET.
A link to the live and archived webcast may be accessed on the Sotera Health website under the Investor Relations section: https://investors.soterahealth.com/events-and-presentations.
About Sotera Health:
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health goes to market through three businesses – Sterigenics®, Nordion® and Nelson Labs®. Sotera Health is committed to its mission, Safeguarding Global Health®.
INVESTOR RELATIONS CONTACTS:
| Sally J. Curley, IRC | Jenny Kobin |
| Curley Global IR, LLC | IR Advisory Solutions |
| IR@soterahealth.com | IR@soterahealth.com |
MEDIA CONTACT:
Kristin Gibbs
Chief Marketing Officer, Sotera Health
kgibbs@soterahealth.com
Source: Sotera Health Company
